ReviewOpen forum infectious diseases2025
Approaches to Offering Hepatitis C Treatment at Syringe Services Programs in the United States: A Scoping Review.
Review in Open forum infectious diseases, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
6 citing papers in PubMed.
- Mobile Telemedicine for Treating Chronic Hepatitis C Among Rural People Who Inject Drugs: A Randomized Clinical Trial.JAMA network open · 2026Trial
- Exploring Sexually Transmitted and Bloodborne Infection Rates in Florida After Implementation of Syringe Services Programs: A Quasi-Experimental Study.AJPM focus · 2026Article
- Review
- Drug Use and Social Connectivity Related to Hepatitis C Infection Among Rural People Who Use Drugs.Journal of viral hepatitis · 2026Article
- Syringe Services Participants' Preferences for Wound Care, HIV/Hepatitis C Virus Screening, and Opioid Use Disorder Treatment: A Discrete Choice Experiment.Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research · 2026Article
- Implementation Evaluation of a Multicomponent Intervention to Address the Infectious Disease and Overdose Syndemic Among People Who Use Drugs in Rural Settings.Journal of public health management and practice : JPHMPArticle
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
Background: Innovative strategies are required to treat hepatitis C (HCV) among people who inject drugs (PWID). Integration of HCV treatment in syringe services programs (SSPs) may improve access, although multiple implementation challenges have been described. Methods: We performed a scoping review of published models of HCV treatment integrated in SSPs in the United States. Results: We found 13 articles including randomized controlled trials, observational studies, cohort analyses, and qualitative analyses that described a variety of approaches to integration that produced significant improvements in treatment initiation and cure compared with a referral-based standard of care. Variations in delivery models (mobile unit vs brick-and-mortar sites), provider location (on-site vs telehealth), pretreatment evaluation, pharmacy access, supportive services (eg, peer navigation) and funding were described. Conclusions: Expansion of these models in the United States would not only contribute to HCV elimination but also create opportunities for the provision of other key healthcare services to this important population.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.